Ethical Issues of Gene Therapy

The world trade market for cell and gene based therapies is expected to greater than the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell based therapies are high impact disease areas with significant incurable needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases gene therapies should then not be rushed to market but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers.

 

    Related Conference of Ethical Issues of Gene Therapy

    November 26-27, 2019

    International Conference On Genomics and Molecular Biology

    Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
    November 26-27, 2019

    International Conference on Cell and Gene Therapy

    Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    June 28-30 2020

    Stroke Summit 2020

    June 28-29 2020

    Geneticsengineering-Insight-2020

    London, UK
    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    16-11-2020

    molecularbiology-cs-2020

    UAE,Dubai
    December 07- 08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia

    Ethical Issues of Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in